Table 1 Characterization of dual-targeted nanoparticles with different amount of melittin
From: Effective treatment of metastatic sentinel lymph nodes by dual-targeting melittin nanoparticles
|  | R4F (μmol) | MLT (μmol) | Size (d. nm) | Zeta potential (mV) |
|---|---|---|---|---|
HA-HPPS | 0.298 ± 0.019 | – | 43.5 ± 1.8 | − 6.18 ± 1.61 |
MLT-HA HPPS (0.18 μmol MLT) | – | 0.076 ± 0.009 | 41.2 ± 2.1 | 10.53 ± 0.57 |
MLT-HA-HPPS (0.36 μmol MLT) | – | 0.043 ± 0.014 | 45.1 ± 2.8 | 6.27 ± 0.41 |